calendar
4,255 catalysts · 4,207 phase readout · 2,217 8k filing · 282 earnings · 172 phase 2 completion · 110 drug shortage · 73 phase 1 completion
4,255 catalysts · 4,207 phase readout · 2,217 8k filing · 282 earnings · 172 phase 2 completion · 110 drug shortage · 73 phase 1 completion
Sponsor: Singapore General Hospital. Phase: NA. Conditions: Pressure Injuries, Caregiver, Community Dwelling Older Adult
Sponsor: Tanta University. Phase: PHASE3. Conditions: Chronic Anal Fissure
Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Healthy Participants
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE2. Conditions: Obesity, Diet Therapy, Weight Loss, Weight Gain, Nutrition Therapy
Sponsor: Methodist Health System. Phase: . Conditions: COVID-19
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: ICB-refractory Melanoma
Sponsor: OrthoCarolina Research Institute, Inc.. Phase: NA. Conditions: Phantom Limb Pain After Amputation
Sponsor: Albert Einstein College of Medicine. Phase: NA. Conditions: Substance Use Disorders, Chronic Pain, Opioid Use Disorder, Back Pain Lower Back Chronic
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: COVID-19
Sponsor: Geisinger Clinic. Phase: NA. Conditions: Emergency Service, Hospital
Sponsor: IntoCell, Inc. Phase: PHASE1. Conditions: Metastatic Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Triple Negative Breast Cancer, Metastatic Solid Tumor
Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD
Sponsor: University of British Columbia. Phase: . Conditions: Cystic Fibrosis, Lung Diseases
Sponsor: University of Minnesota. Phase: . Conditions: Cystic Fibrosis
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Acute Ovarian Failure, Infertility, Early Menopause And Infertility In Females After Treatment For Childhood Cancer
Sponsor: Hoffmann-La Roche. Phase: . Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema
Sponsor: Gregoire Wuerzner; MD. Phase: NA. Conditions: Chocolate Consumption
Sponsor: Centre Hospitalier Sud Francilien. Phase: . Conditions: Type 1 Diabetes
Sponsor: Brown University. Phase: NA. Conditions: Opioid Use Disorder
Sponsor: Çankırı Karatekin University. Phase: . Conditions: Diabetes (DM), Periodontitis, Periodontitis (Stage 3), Micronuclei Count
Sponsor: Ulla Schierup Nielsen. Phase: . Conditions: Hyperprolactinemia, Puberty Disorders, Metabolic Syndrome, Growth Disorders, Antipsychotics and Neuroleptics Toxicity
Sponsor: Ataturk University. Phase: NA. Conditions: Healthy Adolescents
Sponsor: Essentia Health. Phase: PHASE3. Conditions: Familial Hypercholesterolemia, Cholesterol, Elevated, Genetic Disease
Sponsor: Pfizer. Phase: PHASE1. Conditions: Healthy Adults, Healthy
Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Surgery--Complications, Perioperative/Postoperative Complications, Acute Kidney Injury, Hospital Mortality
Sponsor: Spirair, Inc. Phase: NA. Conditions: Sinus Endoscopic Surgery, Turbinate
Sponsor: Avenzo Therapeutics, Inc.. Phase: PHASE1. Conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Prostate Cancer
Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Ischemic Cardiomyopathy
Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Prostatic Neoplasms
Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Cancer
Sponsor: Gadjah Mada University. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)
Sponsor: Hacettepe University. Phase: NA. Conditions: Stress
Sponsor: Óscar Cano Pérez. Phase: NA. Conditions: Bradycardia
Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Ureteral Stent-Related Symptom
Sponsor: Örebro University, Sweden. Phase: NA. Conditions: Healthy Participants
Sponsor: Implicit Bioscience. Phase: PHASE1. Conditions: Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Left Ventricular Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy 1, Arrhythmogenic Cardiomyopathy, ACM, ARVC, PKP2
Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Dysphagia, Laryngeal Edema
Sponsor: Milestone Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Atrial Fibrillation
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Isolated Non-acquired Growth Hormone Deficiency
Sponsor: University of California, San Francisco. Phase: NA. Conditions: Cerebral Palsy, Cerebral Palsy (CP), Cerebral Palsy Infantile, Infant
Sponsor: Ajay Wasan, MD, Msc. Phase: PHASE2. Conditions: Chronic Low Back Pain, Negative Affectivity
Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Metastatic Castration-resistant Prostate Cancer
Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Stage II-III Gastric Cancer
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Smoking Cessation
Sponsor: University of Southampton. Phase: . Conditions: Fractures in the Elderly
Sponsor: RenJi Hospital. Phase: EARLY_PHASE1. Conditions: CAR-T Cell Therapy
Sponsor: Dr Bruno Chumpitazi, M.D.. Phase: PHASE2. Conditions: Irritable Bowel Syndrome
Sponsor: Shanghai Geriatric Medical Center. Phase: . Conditions: Postoperative Cognitive Dysfunction (POCD), Cardiac Diseases Requiring Surgery
Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Lumbar Stenosis, Familial